Sunday, September 13, 2026
spot_img

Interim consolidated financial statement of Grigeo Group AB covering 9 months of 2025

Over 9 months of 2025, Grigeo Group AB company group (hereinafter – the Group), consisting of Grigeo Group AB, Grigeo Packaging UAB, Grigeo Baltwood UAB, Grigeo Klaipėda AB, Mena Pak AT, Grigeo Recycling UAB, Grigeo Recycling SIA, Grigeo Paper Packaging UAB, Grigeo Tissue UAB, Grigeo Hygiene UAB, Grigeo Tissue sp. z o.o and Energia Cieplna Niedomice sp. z o.o achieved the consolidated sales turnover of EUR 173.0 million. It is by EUR 14.9 million more than over respective period of 2024.

Over the reporting period, the Group earned EUR 15.4 million profit before taxes, which is by EUR 1.2 million less than in the same period in 2024.

Earnings before interest, taxes, depreciation, and amortization (EBITDA) of the Group, if compared with 9 months of 2024, increased by EUR 1.0 million and reached EUR 24.7 million.

The following table summarizes 9-month performance numbers stated in this announcement:

Indicator, EUR million 2025 2024 Change
Revenue 173.0 158.2 9%
EBITDA* 24.7 23.7 4%
Profit before tax (EBT) 15.4 16.7 (7%)

*Calculations are disclosed in Note 17 of attached statements.

More details on these changes are presented in interim management report and unaudited consolidated financial statements of Grigeo Group AB covering 9 months of 2025 (see attachments).

Tomas Jozonis

Chief Executive Officer

+370 5 243 58 01

Attachment

  • 2025Q3 interim report EN 09 30

Powered by SlickText.com

Hot this week

Capgemini signs a definitive agreement to sell Capgemini Government Solutions

Media RelationsSam ConnattyTel.: +44 (0) 7811 486517E-Mail: [email protected] ...

Michelin | Disclosure of the total number of voting rights and of the number of shares making up the company’s capital

Clermont-Ferrand, September 11th, 2026 COMPAGNIE GÉNÉRALE DES...

Clearmind Enrolls First Patients with Alcohol Use Disorder in CMND-100 Clinical Trial

Vancouver, Canada, Sept. 11, 2026 (GLOBE NEWSWIRE) --...

Allarity Therapeutics Announces Strategic Capital Allocation for Filing of SPAC Registration Statement

  TARPON SPRINGS, Fla., September 11, 2026 –...

Topics

spot_img

Related Articles

Popular Categories

spot_img